Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
In the last 90 days, Faeth Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Faeth Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +15 vs. Q1 2026
- Shares held
- 14.1M
- +11.9M (+552.6%) vs. Q1 2026
- Total value
- $333.8M
- +$265.8M (+391.1%) vs. Q1 2026
- New holders
- 22
- 17 more added
- Sold out
- 7
- 2 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $333.8M |
| Q1 2026 | 30 | $68.0M |
| Q4 2025 | 10 | $514.8K |
| Q3 2025 | 9 | $466.2K |
| Q2 2025 | 10 | $600.0K |
| Q1 2025 | 20 | $760.2K |
| Q4 2024 | 24 | $1.16M |
| Q3 2024 | 19 | $1.32M |
| Q2 2024 | 24 | $1.31M |
| Q1 2024 | 25 | $2.43M |
| Q4 2023 | 24 | $2.05M |
| Q3 2023 | 23 | $2.38M |
| Q2 2023 | 26 | $3.58M |
| Q1 2023 | 27 | $4.71M |
| Q4 2022 | 28 | $3.93M |
| Q3 2022 | 31 | $4.47M |
| Q2 2022 | 40 | $7.06M |
| Q1 2022 | 43 | $8.21M |
| Q4 2021 | 38 | $19.7M |
| Q3 2021 | 42 | $37.1M |
| Q2 2021 | 34 | $22.7M |
| Q1 2021 | 40 | $45.8M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Faeth Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 4 | $100 | 0.00% | 00.0% | Unchanged |
| UMA Financial Services, Inc. | 28 | $700 | 0.00% | +28 | New |
| Quarry LP | 32 | $800 | 0.00% | +32 | New |
| JPMorgan Chase & Co | 40 | $929 | 0.00% | +8+25.0% | Added |
| BNP Paribas Arbitrage, SA | 113 | $2.83K | 0.00% | +104+1,155.6% | Added |
| Royal Bank of Canada | 509 | $13.0K | 0.00% | +509 | New |
| Tower Research Capital LLC (TRC) | 650 | $16.3K | 0.00% | −846−56.6% | Reduced |
| BlackRock, Inc. | 3,402 | $85.0K | 0.00% | +3,402 | New |
| China Universal Asset Management Co., Ltd. | 3,600 | $90.0K | 0.01% | +3,600 | New |
| Vanguard Fiduciary Trust Co | 6,307 | $157.7K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 9,608 | $240.2K | 0.00% | +9,608 | New |
| Vanguard Capital Management LLC | 10,115 | $252.9K | 0.00% | +2,365+30.5% | Added |
| Citadel Advisors LLC | 12,296 | $307.4K | 0.00% | +12,296 | New |
| Barclays PLC | 12,412 | $310.3K | 0.00% | +12,412 | New |
| Superstring Capital Management LP | 14,175 | $354.4K | 0.22% | +14,175 | New |
| Geode Capital Management, LLC | 14,616 | $365.4K | 0.00% | +5,115+53.8% | Added |
| Catalio Capital Management, LP | 14,718 | $367.9K | 0.07% | 00.0% | Unchanged |
| Morgan Stanley | 17,329 | $433.2K | 0.00% | +8,534+97.0% | Added |
| Jane Street Group, LLC | 20,117 | $502.9K | 0.00% | +11,245+126.7% | Added |
| Renaissance Technologies LLC | 20,416 | $510.4K | 0.00% | −11,625−36.3% | Reduced |
| UBS Group AG | 21,541 | $538.5K | 0.00% | +17,012+375.6% | Added |
| Ikarian Capital, LLC | 35,386 | $884.6K | 0.14% | +29,035+457.2% | Added |
| Richmond Investment Services, LLC | 79,731 | $1.99M | 0.63% | +79,731 | New |
| AWM Investment Company, Inc. | 111,343 | $2.78M | 0.24% | +111,343 | New |
| Boothbay Fund Management, LLC | 133,643 | $3.34M | 0.06% | +107,519+411.6% | Added |
| Alyeska Investment Group, L.P. | 144,404 | $3.61M | 0.01% | +144,404 | New |
| Affinity Asset Advisors, LLC | 144,404 | $3.61M | 0.18% | +144,404 | New |
| Patient Square Capital LP | 175,050 | $4.38M | 0.68% | +175,050 | New |
| Boxer Capital Management, LLC | 180,505 | $4.51M | 0.34% | +180,505 | New |
| Marshall Wace, LLP | 206,508 | $5.16M | 0.00% | +140,778+214.2% | Added |
| Cormorant Asset Management, LP | 1,028,242 | $7.66M | 0.39% | +722,020+235.8% | Added |
| Octagon Capital Advisors LP | 361,010 | $9.03M | 0.83% | +361,010 | New |
| ADAR1 Capital Management, LLC | 361,010 | $9.03M | 0.42% | +361,010 | New |
| Franklin Resources Inc | 494,516 | $12.4M | 0.00% | +361,010+270.4% | Added |
| Trails Edge Capital Partners, LP | 515,335 | $12.9M | 2.05% | +390,335+312.3% | Added |
| B Group, Inc. | 610,169 | $15.3M | 8.66% | +610,169 | New |
| Caligan Partners LP | 629,467 | $15.7M | 0.76% | +503,465+399.6% | Added |
| Vivo Capital, LLC | 722,020 | $18.1M | 1.65% | 00.0% | Unchanged |
| Logos Global Management LP | 722,020 | $18.1M | 0.78% | +692,020+2,306.7% | Added |
| Ra Capital Management, L.P. | 722,020 | $18.1M | 0.16% | +722,020 | New |
| Fairmount Funds Management LLC | 722,020 | $18.1M | 1.19% | +722,020 | New |
| Balyasny Asset Management LLC | 1,042,198 | $26.1M | 0.05% | +1,025,993+6,331.3% | Added |
| Baker Bros. Advisors LP | 1,286,411 | $32.2M | 0.16% | +1,286,411 | New |
| Avoro Capital Advisors LLC | 1,444,039 | $36.1M | 0.32% | +1,444,039 | New |
| Suvretta Capital Management, LLC | 2,020,103 | $50.5M | 1.06% | +1,985,554+5,747.1% | Added |
| Millennium Management LLC | 0 | $0 | 0.00% | −146,565−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −132,873−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −61,568−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −58,001−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −33,025−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −20,333−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −18,337−100.0% | Sold out |